Nordic Nanovector: Promising results from preclinical studies with a novel CD37-targeted alpha therapy for B-cell tumours to be presented at ASH
Oslo, Norway, 1 November 2018 Nordic Nanovector ASA (OSE: NANO) announces that an abstract reporting promising results from a research collaboration to develop a novel CD37-targeting alpha therapy for B-cell malignancies has been published. The complete results will be presented in a poster at the 60th American Society of Hematology (ASH) Annual Meeting & Exposition (1-4 December 2018 in San Diego, CA, USA). The research collaboration was established in June 2015 with Orano Med (formerly known as AREVA Med) to develop and investigate a next-generation targeted alpha therapy,
Gasum subsidiary Skangas entered into an agreement with parts of the Gothia Tanker Alliance to supply liquefied natural gas (LNG) as fuel. The new agreement comprises current as well as new vessels with LNG propulsion soon to come.The main Swedish shipping companies that will get the advantage of the supply agreement with Skangas are Furetank Rederi AB, Erik Thun AB and Rederi AB Älvtank. These shipping companies have invested in total six new LNG fueled vessels and together with the existing Fure West they are all jointly operated by the Gothia Tanker Alliance.
The Swedish Shipowners’
· Invesdor won the regional fintech category of the Nordic Startup Awards, whose grand finale gala was held in Copenhagen on Tuesday 30 October · The Finnish company triumphed over finalists from Sweden, Denmark, Norway and Iceland in a combination of jury and public vote · Invesdor will participate in the finals of the Global Startup Awards, to be held in Guangzhou in DecemberWinners were determined by a combination of popular vote and expert panel. To make it to the finals, the competing companies had won their respective national awards in September. The original competitor pool
